weiqi wang | Data collection | Young Scientist Award

Dr. weiqi wang | Data collection | Young Scientist Award

Shandong First Medical University Affiliated Provincial Hospital | China

Publication Profile

Scopus

Dr. Weiqi Wang: Bio Summary 🌟

Dr. Weiqi Wang is a dedicated physician specializing in Neurology at the Shandong First Medical University Affiliated Provincial Hospital in China. With a robust background in neurology, his research focuses on neurovascular unit injury mechanisms following subarachnoid hemorrhage (SAH). He is currently involved in leading and contributing to cutting-edge studies on therapeutic strategies for neurological disorders, particularly in the context of brain-targeted stem cell therapy and neurodegenerative diseases.

🎓 Education

  • PhD in Neurology – Qingdao University, 2018-2021

  • Master’s in Neurology – Shandong First Medical University, 2015-2018

  • Bachelor’s in Clinical Medicine – Jining Medical University, 2010-2015

💼 Professional Experience

  • Physician, Department of Neurology – Shandong First Medical University Affiliated Provincial Hospital (July 2021 – Present)

  • Involved in clinical practice while pursuing various research projects centered on brain injury and neurovascular protection mechanisms.

📑 Academic Citations & Key Publications

  • Wang WeiQi, et al. TAT-mGluR1 Attenuation of Neuronal Apoptosis after Subarachnoid Hemorrhage, ACS Chemical Neuroscience, 2019. (Co-first author)

  • Zhang Cheng, et al. Selective mGluR1 Negative Allosteric Modulator Reduces Blood-Brain Barrier Permeability and Cerebral Edema, Translational Stroke Research, 2020. (Co-first author)

  • Wang HongBin, et al. Negative Allosteric Modulator of mGluR1 Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage, ACS Chemical Neuroscience, 2020. (Co-first author)

  • Zhou XiaoYan, et al. TAT-HSP27 Peptide Improves Neurologic Deficits via Reducing Apoptosis, Frontiers in Cellular Neuroscience, 2022. (Co-first author)

  • Hou YaJun, et al. NT157 Inhibits Glioma Cell Proliferation by Upregulating DR5 Expression, Biomedicine & Pharmacotherapy, 2022. (Other author)

🛠️ Technical Skills

  • Expertise in experimental neurobiology techniques, including stem cell therapies, neurovascular unit research, and gene regulation in neurological disorders.

  • Proficient in animal models, biochemical assays, and molecular biology methods.

📚 Teaching Experience

  • Actively involved in educating medical students and interns in clinical neurology and neurophysiology at Shandong First Medical University, fostering the next generation of healthcare professionals.

🔬 Research Interests

  • Neuroprotection mechanisms in subarachnoid hemorrhage (SAH) and traumatic brain injury.

  • Targeted therapies using stem cell-derived exosomes and signaling pathways, such as mGluR1 and ERK1/2, in treating neurovascular disorders and neurodegenerative diseases.

  • Understanding the molecular and cellular mechanisms behind neuronal apoptosis and recovery after brain injury.

📚 Top Notes Publications 

 TAT-mGluR1 Attenuation of Neuronal Apoptosis through Prevention of MGluR1α Truncation after Experimental Subarachnoid Hemorrhage
  • Authors: Wang WeiQi, Han Ping, Xie RongXia, Yang MingFeng, Zhang Cheng, Mi QiongJie, Sun BaoLiang, Zhang ZongYong
    Journal: ACS Chemical Neuroscience
    Year: 2019
Selective mGluR1 Negative Allosteric Modulator Reduces Blood-Brain Barrier Permeability and Cerebral Edema After Experimental Subarachnoid Hemorrhage
  • Authors: Zhang Cheng, Jiang Ming, Wang WeiQi, Zhao ShiJun, Yin YanXin, Mi QiongJie, Yang MingFeng, Song YuQiang, Sun BaoLiang, Zhang ZongYong
    Journal: Translational Stroke Research
    Year: 2020
 Negative Allosteric Modulator of mGluR1 Improves Long-Term Neurologic Deficits after Experimental Subarachnoid Hemorrhage
  • Authors: Wang HongBin, Wang WeiQi, Wu QingJian, Hou YaJun, Li HanXia, Yang HuiJuan, Yang MingFeng, Sun BaoLiang, Zhang ZongYong
    Journal: ACS Chemical Neuroscience
    Year: 2020

Article: TAT-HSP27 Peptide Improves Neurologic Deficits via Reducing Apoptosis After Experimental Subarachnoid Hemorrhage
  • Authors: Zhou XiaoYan, Sun JingYi, Wang WeiQi, Li ShuXian, Li HanXia, Yang HuiJuan, Yang MingFeng, Yuan Hui, Zhang ZongYong, Sun BaoLiang, Han JinXiang
    Journal: Frontiers in Cellular Neuroscience
    Year: 2022

 NT157 Inhibits Cell Proliferation and Sensitizes Glioma Cells to TRAIL-Induced Apoptosis by Upregulating DR5 Expression
  • Authors: Hou YaJun, Li DaWei, Wang WeiQi, Mao LeiLei, Fu XiaoYan, Sun BaoLiang, Fan CunDong
    Journal: Biomedicine & Pharmacotherapy
    Year: 2022

Mirela Drtaghici | neurologie | Best Researcher Award

Mrs. Mirela Drtaghici | neurologie | Best Researcher Award

IC Fundeni, Romania

Author Profile

Orcid

Early Academic Pursuits 🎓

Dr. Mirela Ramona Drtaghici, currently a project coordinator at IC Fundeni in Bucharest, Romania, began her academic journey with a strong focus on medicine and neurology. In 2006, she obtained her degree as a specialist in Neurology. Following that, she pursued additional certifications and qualifications, completing postgraduate studies in ultrasonography (2008), electroencephalography (2009), and electromyography (2015). In 2013, she achieved her title as a primary physician in Neurology and later, in 2017, earned an advanced certification in healthcare management. This educational foundation set the stage for her career as an expert in the field of neurology.

Professional Endeavors 💼

Dr. Drtaghici has a rich career, highlighted by her position as a primary neurologist at IC Fundeni in Bucharest, Romania, since 2012. Her commitment to the healthcare field is evident through her continued contributions to neurological diagnostics and research. In 2017, she joined the team of investigators for the National Health Program at IC Fundeni, focusing on the neurological examination and electromyography of patients diagnosed with TTR amyloidosis.

In 2018, Dr. Drtaghici presented at the 12th World Congress on Neurology, where she delivered a paper on the neurological aspects of a case of TTR amyloidosis with the GLU 54 GLN mutation. Her professional endeavors have centered on advancing the understanding and treatment of neurological conditions, especially in the realm of rare diseases such as amyloidosis.

Contributions and Research Focus 🔬

Dr. Drtaghici’s research has significantly contributed to the field of neurology, particularly regarding amyloidosis TTR. She actively participates in national programs that investigate and treat this condition, providing crucial insights into the neurological impacts of the disease. In 2019, she was involved in a symposium on the diagnosis and treatment of amyloidosis, emphasizing her growing expertise in this niche area of neurology. Her dedication to researching new diagnostic methods and treatments continues to advance the knowledge base within her professional network.

Impact and Influence 🌍

Dr. Drtaghici’s work has a significant impact on both the medical community and the patients she treats. Her role as an investigator in the National Health Program has allowed her to influence medical practices in the diagnosis and treatment of TTR amyloidosis. Additionally, her contributions to major medical congresses, such as the World Congress on Neurology, underscore her international influence in the field of neurology. She is helping shape the way amyloidosis is understood and treated in Romania and beyond.

Academic Cites 📚

specific academic citations are not provided, Dr. Drtaghici’s academic and professional achievements have contributed to her growing recognition in the field. Presentations like the one at the World Congress on Neurology serve to disseminate her knowledge to a wider audience, promoting scholarly discussion around the diagnosis and management of amyloidosis and related neurological conditions. Her work continues to inspire and inform other medical professionals engaged in similar research.

Technical Skills ⚙️

Dr. Drtaghici possesses advanced technical skills in a variety of diagnostic tools essential for modern neurology practice. These include proficiency in electroencephalography, electromyography, and Doppler ultrasonography for cerebral examinations. Her expertise in these areas allows her to provide detailed neurological assessments and contribute meaningfully to her role in amyloidosis research.

Teaching Experience 🏫

Although her current role primarily focuses on clinical practice and research, Dr. Drtaghici has actively contributed to the educational field by sharing her knowledge at medical conferences and symposia. Her involvement in events such as the Romanian Society of Hematology’s symposium reflects her teaching role, where she imparts her knowledge on the diagnosis and treatment of amyloidosis. This sharing of expertise aids in the professional development of other healthcare providers in the field.

Legacy and Future Contributions 🔮

As a physician and researcher, Dr. Drtaghici’s legacy is being shaped by her continuous work in the areas of neurology and amyloidosis. Her future contributions are likely to be centered around further advancing diagnostic techniques and treatment methodologies, especially in the realm of rare diseases. With her role in the National Health Program and her commitment to research, Dr. Drtaghici is poised to leave a lasting mark on both Romanian and international neurology, influencing future generations of neurologists and healthcare professionals.

 

Top Noted Publication📖

Authors: Mirela Ramona Draghici, Sorina-Nicoleta Badelita, Andreea Jercan, Oana Obrișcă, Crisanda Vîlciu, Monica Popescu, Adina Turcu-Stiolica, Coriu D

Journal: Medicina

Year: 2024